Delivery Order SPE2DR25D9133-SPE2DR26FCGA2
Award Date 5/6/26
Potential Completion Date 5/7/26
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $25,326.56 delivery order to DMS Pharmaceutical Group Inc. on April 27, 2026, for JAKAFI 10 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense military...
- The Defense Logistics Agency issued a $25,165.90 delivery order to DMS Pharmaceutical Group Inc. on April 29, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for JAKAFI 15 MG tablets (60-count units). PPV-G GEN V is a single-award indefinite delivery contract through which the Defense Logistics Agency authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on May 5, 2026, for JAKAFI 5 mg tablets (60-count units) with a ceiling value of $38,162.76. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. DMS Pharmaceutical Group Inc. is a woman-owned small business headquartered in Park Ridge, Illinois, the sole...
- The Defense Logistics Agency issued a $37,989.81 delivery order to DMS Pharmaceutical Group Inc. on April 27, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of JAKAFI 10 mg tablets (60-count units). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for branded and generic prescription drugs, biologics, over-the-counter medications, vaccines, and medical consumables to Department of Defense military healthcare...
- The Defense Logistics Agency issued a $12,582.95 delivery order to DMS Pharmaceutical Group Inc. on March 16, 2026, for JAKAFI 15 mg tablets (60-count) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's comprehensive pharmaceutical supply contract supporting Department of Defense healthcare operations globally with branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables....
- The Defense Logistics Agency issued a $37,767.33 delivery order to DMS Pharmaceutical Group Inc. on May 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for JAKAFI 20MG tablets (60-count units). DMS Pharmaceutical is a woman-owned small business and the sole regional prime vendor under PPV-G GEN V, holding a single-award indefinite delivery contract (SPE2DX) with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. The underlying...
- The Defense Logistics Agency issued a $12,582.95 delivery order to DMS Pharmaceutical Group Inc. on April 15, 2026, for JAKAFI 15 mg tablets (60-count) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a DLA-administered indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on May 6, 2026, for JAKAFI 15 mg tablets (60-count), with a ceiling value of $12,582.95 and ultimate completion date of May 7, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), the Defense Logistics Agency's single-award indefinite delivery contract framework for pharmaceutical supply to...
- The Defense Logistics Agency issued a $12,603.07 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 25, 2026, for JAKAFI 25 mg tablets (60-count unit). The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 24, 2026, for JAKAFI 5 mg tablets (60-count units) with a ceiling value of $25,441.84. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables...